Literature DB >> 34099470

Constrictive pericarditis with pericardial calcification.

Kevin R An1, Steve K Singh2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34099470      PMCID: PMC8203255          DOI: 10.1503/cmaj.202346

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
A 71-year-old man with a history of a locally excised melanoma presented to his family physician with 2 years of progressive lower leg edema, ascites, weight loss, fatigue and dyspnea on exertion. His medical history also included a protracted, flu-like illness 3 years prior. As part of a workup for recurrent melanoma that was otherwise unremarkable, a computed tomography scan of the patient’s chest showed pericardial and epicardial calcifications, consistent with a diagnosis of constrictive pericarditis (Figure 1A). A transthoracic echocardiogram showed a pericardial effusion, thickened pericardium, septal bounce and dilated inferior vena cava. Cardiac catheterization showed equalization of diastolic pressures in all 4 chambers at 20 (normal range 2–12) mm Hg, confirming constrictive pericarditis.
Figure 1:

Constrictive pericarditis in a 71-year-old man. A) Computed tomography scan with contrast of the patient’s chest showing circumferential calcification of the pericardium (white arrow) and epicardium (yellow arrow). B) Intraoperative image of the patient’s white calcific heart, showing the calcified pericardium (white arrow) and epicardium (yellow arrow).

Constrictive pericarditis in a 71-year-old man. A) Computed tomography scan with contrast of the patient’s chest showing circumferential calcification of the pericardium (white arrow) and epicardium (yellow arrow). B) Intraoperative image of the patient’s white calcific heart, showing the calcified pericardium (white arrow) and epicardium (yellow arrow). A pericardiectomy revealed a white calcific heart; we resected the pericardium anterior to the phrenic nerves bilaterally to relieve cardiac constriction (Figure 1B). Pathology showed no evidence of malignancy, and specimen cultures were negative for tuberculosis. Although causality cannot be firmly established, we consider it most likely that the constrictive pericarditis was a long-term sequela of a viral infection. The patient’s presenting symptoms of abdominal distension, lower leg swelling, fatigue and shortness of breath steadily improved postoperatively, and he was discharged from hospital 2 weeks after surgery. Constrictive pericarditis is a chronic inflammatory condition of the pericardium, with an incidence of 1 in 100 000 in the United States.1 It is often initiated by idiopathic or viral pericarditis, previous cardiac surgery, mediastinal radiation or tuberculosis, and is thought to be triggered by an immune response, leading to the development of a fibrous or calcific pericardium.1,2 In one series, 28% of resected pericardium specimens were grossly calcified on pathology.3 Symptoms are similar to those of heart failure, and the condition is difficult to distinguish from restrictive cardiomyopathy.2 Bilateral cardiac catheterization is the gold standard diagnostic test,4 and definitive management is pericardiectomy.
  4 in total

1.  Surgical pathology of the parietal pericardium: a study of 344 cases (1993-1999).

Authors:  K Y Oh; M Shimizu; W D Edwards; H D Tazelaar; G K Danielson
Journal:  Cardiovasc Pathol       Date:  2001 Jul-Aug       Impact factor: 2.185

2.  US National Trends in the Management and Outcomes of Constrictive Pericarditis: 2005-2014.

Authors:  Makoto Mori; Clancy W Mullan; Syed Usman Bin Mahmood; Sameh Yousef; Keith J Pelletier; Abeel A Mangi; Arnar Geirsson
Journal:  Can J Cardiol       Date:  2019-05-20       Impact factor: 5.223

Review 3.  Constrictive Pericarditis.

Authors:  Terrence D Welch; Jae K Oh
Journal:  Cardiol Clin       Date:  2017-11       Impact factor: 2.213

Review 4.  Constrictive pericarditis--a curable diastolic heart failure.

Authors:  Faisal F Syed; Hartzell V Schaff; Jae K Oh
Journal:  Nat Rev Cardiol       Date:  2014-07-29       Impact factor: 32.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.